Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cardiol Therapeutics Inc T.CRDL.W.A


Primary Symbol: T.CRDL Alternate Symbol(s):  CRDL

Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

Recent & Breaking News (TSX:CRDL)

Cardiol Therapeutics Commences Trading on the OTCQX

Newsfile May 30, 2019

OTC Markets Group Welcomes Cardiol Therapeutics Inc. to OTCQX

PR Newswire May 30, 2019

Cardiol Therapeutics at the Intersection of Pharmaceutical CBD and Biotech, Plus Exclusive CEO Interview -- CFN Media

Newsfile May 7, 2019

Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A

Newsfile March 28, 2019

The Science Behind Medical Marijuana is Flawed -- CFN Media

GlobeNewswire March 21, 2019

Cardiol Therapeutics to Present at the 2019 LD Micro Virtual Conference

Accesswire March 12, 2019

LD Micro Virtual Conference Is Live, March 12th and 13th

Accesswire March 12, 2019

Cardiol Therapeutics Appoints Thomas Moffatt as Chief Commercial Officer

Newsfile March 6, 2019

Cardiol Therapeutics Introducing Major Supply of Pharmaceutical CBD to Meet Supply Crunch -- CFN Media

Newsfile January 30, 2019

Cardiol Therapeutics Inc. Closes the Market

Canada NewsWire January 28, 2019

Cardiol Therapeutics Inc. Closes Over-Allotment

Newsfile January 18, 2019

IIROC Trade Resumption - CRDL

Canada NewsWire December 20, 2018

Cardiol Therapeutics Completes Initial Public Offering and the Company's Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols "CRDL" and "CRDL.WT"

Newsfile December 20, 2018

IIROC Trading Halt - CRDL

Canada NewsWire December 20, 2018